Trials / Completed
CompletedNCT01126684
Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
EFFECTS OF ATORVASTATIN ON BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the possible effects of atorvastatin on ambulatory blood pressure, urinary albumin excretion, insulin resistance and arterial stiffness in hypertensive patients, beyond those on lipid profile. Glycemic parameters, "novel" cardiovascular risk factors and safety parameters will be also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | 10 mg of atorvastatin once daily for six months |
| DRUG | Placebo | placebo once daily for six months |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-12-01
- First posted
- 2010-05-20
- Last updated
- 2010-05-20
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01126684. Inclusion in this directory is not an endorsement.